1
|
Latt PM, Soe NN, Fairley CK, Chow EPF, Johnson CC, Shah P, Maatouk I, Zhang L, Ong JJ. Machine learning for personalized risk assessment of HIV, syphilis, gonorrhoea and chlamydia: A systematic review and meta-analysis. Int J Infect Dis 2025; 157:107922. [PMID: 40339784 DOI: 10.1016/j.ijid.2025.107922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2025] [Revised: 04/21/2025] [Accepted: 04/30/2025] [Indexed: 05/10/2025] Open
Abstract
BACKGROUND Machine learning (ML) shows promise for sexually transmitted infection (STI) risk prediction, but systematic evidence of its effectiveness remains fragmented. METHODS We systematically searched six electronic databases, three preprint archives and conference proceedings (January 2010-April 2024). Studies reporting quantitative performance metrics for supervised ML-based STI risk prediction models were included. We used a bivariate random-effects model to estimate pooled sensitivity, specificity and area under the curve (AUC). The risk of bias was assessed using the Prediction model Risk of Bias Assessment Tool. We conducted sequential analyses of studies with complete and reconstructed confusion matrices. Subgroup analyses and meta-regression explored potential sources of heterogeneity. RESULTS Among 3877 records screened, 25 studies comprising 45 unique models met inclusion criteria. For HIV, analysis of studies with complete confusion matrices (7 studies, 9 contingency tables) demonstrated summary AUC of 0.91 (95% CI: 0.88-0.93), pooled sensitivity 0.84 (0.76-0.90) and specificity 0.84 (0.70-0.93). Substantial heterogeneity persisted across subgroups (I² > 98%). For other STIs, individual studies reported AUCs ranging from 0.75-0.87 for syphilis (n = 5), 0.73-1.00 for gonorrhoea (n = 6) and 0.67-1.00 for chlamydia (n = 6). DISCUSSION While ML models show promising performance, particularly for HIV, significant heterogeneity complicates interpretation. Future research should prioritize external validation, standardized guidelines and multi-centred robust implementation studies to evaluate clinical impact.
Collapse
Affiliation(s)
- Phyu M Latt
- Artificial Intelligence and Modelling in Epidemiology Program, Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia; School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
| | - Nyi N Soe
- Artificial Intelligence and Modelling in Epidemiology Program, Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia; School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
| | - Christopher K Fairley
- School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia
| | - Eric P F Chow
- School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
| | - Cheryl C Johnson
- Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland
| | - Purvi Shah
- Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland; Regional Support Team, Asia Pacific, UNAIDS, Bangkok, Thailand
| | - Ismail Maatouk
- Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland
| | - Lei Zhang
- Artificial Intelligence and Modelling in Epidemiology Program, Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia; School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Clinical Medical Research Centre, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
| | - Jason J Ong
- School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK
| |
Collapse
|
2
|
Pley C, Jung L, Nurdin N, Venkatesan T, Naidu VV, James R, Kmentt L, Florence I, Delight E, Guo C, Abdel Salam AP. Duration of viral persistence in human semen after acute viral infection: a systematic review. THE LANCET. MICROBE 2025; 6:101013. [PMID: 39672180 DOI: 10.1016/j.lanmic.2024.101013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2024] [Revised: 09/16/2024] [Accepted: 09/30/2024] [Indexed: 12/15/2024]
Abstract
The persistence of viruses in human semen following acute infection can contribute to the ongoing transmission of a disease or cause resurgence after an outbreak has been declared ended. Viral persistence in semen affects embryonic development and male fertility, and the development of drugs and vaccines. We conducted a systematic review of viral persistence in semen in accordance with PRISMA guidelines. 373 original studies were included in this Review after screening 29 739 articles from five databases. Evidence was found of detection of 22 viruses in human semen following acute infection, including pathogens with pandemic potential. In addition to collating the largest evidence base to date on viral detection in semen following acute infection, this Review reports the maximal and median viral persistence (in days) after the onset of illness and evidence for sexual transmission and viability of the viruses in semen. Finally, the Review presents research gaps that need to be prioritised to guide further study of the dynamics of viral persistence in semen.
Collapse
Affiliation(s)
- Caitlin Pley
- Center for Global Health, Charité University Berlin, Berlin, Germany; Guy's and St Thomas' NHS Foundation Trust, London, UK.
| | - Laura Jung
- Division of Infectious Diseases and Tropical Medicine, Leipzig University Medical Center, Leipzig, Germany
| | - Nadra Nurdin
- Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland
| | | | - Vasanth V Naidu
- Institute for Global Health, University College London, London, UK
| | - Rosemary James
- Institute for Global Health, University College London, London, UK; Geneva Centre of Humanitarian Studies, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Federation of European Societies for Tropical Medicine and International Health, Antwerp, Belgium
| | - Laura Kmentt
- Guy's and St Thomas' NHS Foundation Trust, London, UK
| | | | - Ellie Delight
- The London School of Hygiene & Tropical Medicine, London, UK
| | - Christina Guo
- Department of Infectious Diseases, Alfred Health, Melbourne, VIC, Australia
| | | |
Collapse
|
3
|
Murphy K, Shi Q, Hoover DR, Adimora AA, Alcaide ML, Brockmann S, Daubert E, Duggal P, Merenstein D, Dionne JA, Sheth AN, Keller MJ, Herold BC, Anastos K, Aouizerat B. Genetic predictors for bacterial vaginosis in women living with and at risk for HIV infection. Am J Reprod Immunol 2024; 91:e13845. [PMID: 38720636 PMCID: PMC11410097 DOI: 10.1111/aji.13845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 03/24/2024] [Accepted: 04/03/2024] [Indexed: 08/29/2024] Open
Abstract
PROBLEM Bacterial vaginosis (BV) disproportionally impacts Black and Hispanic women, placing them at risk for HIV, sexually transmitted infections and preterm birth. It is unknown whether there are differences by genetic ancestry in BV risk or whether polymorphisms associated with BV risk differ by ancestry. METHODS Women's Interagency HIV Study (WIHS) participants with longitudinal Nugent scores were dichotomized as having (n = 319, Nugent 7-10) or not having BV (n = 367, Nugent 0-3). Genetic ancestry was defined by clustering of principal components from ancestry informative markers and further stratified by BV status. 627 single nucleotide polymorphisms (SNPs) across 41 genes important in mucosal defense were identified in the WIHS GWAS. A logistic regression analysis was adjusted for nongenetic predictors of BV and self-reported race/ethnicity to assess associations between genetic ancestry and genotype. RESULTS Self-reported race and genetic ancestry were associated with BV risk after adjustment for behavioral factors. Polymorphisms in mucosal defense genes including syndecans, cytokines and toll-like receptors (TLRs) were associated with BV in all ancestral groups. CONCLUSIONS The common association of syndecan, cytokine and TLR genes and the importance of immune function and inflammatory pathways in BV, suggests these should be targeted for further research on BV pathogenesis and therapeutics.
Collapse
Affiliation(s)
- Kerry Murphy
- Departments of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States of America
- Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States of America
| | - Quihu Shi
- School of Health Sciences and Practice, New York Medical College, Valhalla, New York, United States of America
| | - Donald R. Hoover
- Department of Statistics and Institute for Health, Health Care Policy and Aging Research Rutgers the State University of New Jersey, Piscataway, NJ, United States of America
| | - Adaora A. Adimora
- Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. United States of America
| | - Maria L. Alcaide
- Department of Medicine, Obstetrics & Gynecology and Public Health, University of Miami Miller School of Medicine
| | - Susan Brockmann
- State University of New York, Health Sciences Center, Brooklyn, NY
| | | | - Priya Duggal
- Department of Epidemiology and International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
| | | | - Jodie A. Dionne
- Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
| | - Anandi N. Sheth
- Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, United States of America
| | - Marla J. Keller
- Departments of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States of America
- Obstetrics & Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, NY, United States of America
| | - Betsy C. Herold
- Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States of America
- Pediatrics, Albert Einstein College of Medicine, Bronx, NY, United States of America
| | - Kathryn Anastos
- Departments of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States of America
- Obstetrics & Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, NY, United States of America
- Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, United States of America
| | | |
Collapse
|